T 1964/18 (Inhibitory anti-NKG2A antibodies/INNATE) of 22.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T196418.20210322
- Date of decision
- 22 March 2021
- Case number
- T 1964/18
- Online on
- 28 January 2022
- Petition for review of
- -
- Application number
- 05825249.5
- IPC class
- C07K 16/28A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Monoclonal antibodies against NKG2A
- Applicant name
- Innate Pharma S.A.
Universita di Genova - Opponent name
- Merck Sharp & Dohme Corp.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted thereto: claims 1 to 34 of the new main request, filed as auxiliary request 1 with the statement of grounds of appeal.